US FDA approves GSK’s HIV drug for patients with limited options The oral treatment from the company’s HIV unit, ViiV Healthcare, has been approved for adults whose HIV infection could…
USFDA launches Project Patient Voice for Cancer Trials The FDA will use this feedback to consider improvements to the website in order to make the information as user-friendly as…
FDA approves first treatment option specifically for patients with epithelioid sarcoma Until now, there were no treatment options specifically for patients with epithelioid sarcoma. The approval of Tazverik provides a…
